Advanced SearchNewsfeedFollowed Companies

Amgen's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Amgen discovers, develops, manufactures and delivers human therapeutics for patients suffering from serious illnesses.

Am... Read more

Based on data from Amgen's latest SEC filings

Annual Revenue

Based on data from Amgen's latest SEC filings

Employees

Robert A. Bradway's photo - Chairman & CEO of Amgen

Chairman & CEO

Robert A. Bradway

CEO Approval Rating

72/100

OVERVIEW

Founded:

1980

Headquarters:

Thousand OaksCalifornia

Status:

PublicNASDAQAMGN

Industry Sector:

Biotechnology

SIC Code:

2836NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Galenica a competitor of Amgen?

I don't know

Trending News for Amgen and Amgen's Competitors

February 15, 2020

BioPortfolio

Roche's Tecentriq a PDL1 Approved in China for Small Cell Lung Cancer

Roche announced China approval to launch its PDL1 immunotherapy Tecentriq atezolizumab. Tecentriq is ... See more »

February 14, 2020

MarketScreener

AbbVie : SEC Filing - 8-K

(marketscreener.com) 0001551152falseCommon Stock, $0.01 Par...https://www.marketscreener.com/ABBVIE-I... See more »

February 15, 2020

Law 360

1st Circ. Revives Sanofi Insulin Injector Antitrust Case

The First Circuit has revived a proposed class action against Sanofi-Aventis, saying the pharmaceutic... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

AbbVie is the top competitor of Amgen. AbbVie was founded in 2013, and its headquarters is in North Chicago, Illinois. AbbVie is in the Pharmaceuticals field. AbbVie has 10,800 more employees than Amgen.

Celgene is seen as one of Amgen's top competitors. Celgene was founded in Summit, New Jersey} in 1986. Like Amgen, Celgene also works within the Biotechnology industry. Compared to Amgen, Celgene generates $14.1B more revenue.

Coherus BioSciences is Amgen's #3 rival. Coherus BioSciences's headquarters is in Redwood City, California, and was founded in 2010. Like Amgen, Coherus BioSciences also competes in the Biotechnology sector. Coherus BioSciences generates 20% of Amgen's revenue.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Robert A. Bradway

Chairman & CEO

- -
19,200
$19M
$1.2B
1

Richard A. Gonzalez

Chairman & CEO

87/100
78
$3.8B
$32.9B
2

Mark J. Alles

Chairman & CEO

76/100
8,852
- -
$17B
3

Denny Lanfear

Chairman & CEO

86/100
232
$244.8M
$232.2M
4

Heather Bresch

CEO

68/100
35,000
$7.9B
$11.4B
5

Jörg Kneubühler

CEO

70/100
4,944
- -
$3.3B
6

Paul Hudson

CEO

82/100
106,859
- -
$41.7B
7

David A. Ricks

Chairman & CEO

73/100
38,680
- -
$24.9B
8

Kaare Schultz

President & CEO

63/100
42,535
$7.7B
$17.5B
9

Albert Bourla

CEO

74/100
92,400
- -
$53B
10

Vasant Narasimhan

CEO

71/100
118,393
- -
$50.3B
The top 10 competitors in Amgen's competitive set are AbbVie, Celgene, Coherus BioSciences, Mylan, Galenica, Sanofi, Eli Lilly, TEVA Pharmaceuticals, Pfizer and Novartis. Together they have raised over 19.6B between their estimated 460.8K employees. Amgen has 19,200 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 42,470.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.2B

Amgen's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 23B. Over the last three quarters, Amgen's revenue has grown by 3.2%. Specifically, in Q3 2019's revenue was $5.7B; in Q2 2019, it was $5.9B; in Q1 2019, it was $5.6B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Nuevolution A/S

May 2019

Source »
$166.8M
Nuevolution develops small molecule drug therapeutics for the treatment of cancer and chronic inflammatory diseases.
Dezima Pharma BV

Sep 2015

Source »
$300M
Dezima Pharma is engaged in the development of novel drugs to treat cardiovascular disease related to dyslipidemia.
Onyx Pharmaceuticals, Inc.

Aug 2013

Source »
$9.7B
Onyx develops and commercializes therapies for the treatment of cancer.
DGI Resolution, Inc.

Dec 2012

Source »
undisclosed
DGI Resolution discovers genetic risk factors for diseases from cardiovascular disease to cancer.
Mustafa Nevzat İlaç Sanayii A.Ş.

Apr 2012

Source »
$700M
-

These are all the companies that Amgen has acquired. Amgen has acquired 12 companies and its latest acquisition was Nuevolution A/S in May 2019. Nuevolution develops small molecule drug therapeutics for the treatment of cancer and chronic inflammatory diseases.

Amgen Funding History

Since Amgen was founded in 1980, it has participated in 1 round of funding. In total Amgen has raised $19.0M. Amgen's funding round was on Apr 1980 for a total of $19.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Apr 1980
$19M
-

Total Funding: $19M

Since Amgen was founded in 1980, it has participated in 1 round of funding. In total Amgen has raised $19.0M. Amgen's funding round was on Apr 1980 for a total of $19.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

GNS is an AI-based platform that offers drug modeling and intervention optimization solutions for the healthcare industry.
$5M
Jan 06, 2020
Series D
-
BeiGene is a biopharmaceutical company that focuses on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer.
$2.8B
Oct 30, 2019
Equity
Feb 03, 2016
Oxford Nanopore develops and commercializes nanopore sequencing products for clinical research companies.
$66M
Oct 17, 2018
Equity
-
Arrowhead focuses on developing medicines that treat intractable diseases by using ribonucleic acid interference mechanism.
$10M
Aug 02, 2018
Unattributed
-
Science 37 develops a cloud-based mobile research platform that allows pharmaceutical companies to conduct clinical trials in patient homes.
$130M
Jun 06, 2018
Series D
-

These are all the companies that Amgen has invested in. Amgen has invested 12 companies and its latest investment was Nuevolution A/S in May 2019. Nuevolution develops small molecule drug therapeutics for the treatment of cancer and chronic inflammatory diseases.

Amgen News

February 6, 2020Investor’s Business Daily

Amgen Stock Relative Strength Climbs Ahead Of Key Drug Data

Amgen sees its Relative Strength Rating hit the 80-plus level ahead of key drug data results.The post... See more »
February 4, 2020MarketScreener

Staff Share Their Commitment to Cancer Research for World Cancer Day

(marketscreener.com) Amgen's mission to serve patients is backed by a commitment to push the boundari... See more »
February 4, 2020DirectorsTalk Interviews

Amgen - Consenus Indicates Potential 13.9% Upside

Amgen with ticker code (AMGN) now have 22 analysts covering the stock with the consensus suggesting a... See more »
February 1, 2020Philanthropy News Digest

Harvard, Amgen Foundation Launch LabXchange Platform

Funded through a $6.5 million commitment from the Amgen Foundation, the platform provides users with ... See more »
January 31, 2020MarketScreener

Amgen Down Over 5%, Worst Performer in the Nasdaq 100 So Far Today -- Data Talk

(marketscreener.com) Amgen Inc. is currently at $213.92, down $12.23 or 5.41% -- Would be lowest clos... See more »
January 31, 2020Investor’s Business Daily

How A Rumored Amgen Takeover Sent This Biotech Stock Flying

Shares of Reata Pharmaceuticals jumped Friday on reports suggesting Amgen could be interested in acqu... See more »
January 31, 2020Seeking Alpha

Reata Pharma up 11% on potential acquisition interest

See more »

Amgen Press Releases

September 18, 2019PR Newswire

Verantos Announces Publication of a Real-World Evidence Collaborative Study with Amgen

PALO ALTO, Calif., Sept. 18, 2019 /PRNewswire/ -- Verantos, the market leader in regulatory-grade rea... See more »
September 9, 2019StreetInsider

Toronto Innovation Acceleration Partners Announces Strategic Partnership with Amgen

Toronto, Ontario, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Toronto Innovation Acceleration Partners (TIAP f... See more »
August 8, 2019PR Newswire

OneOncology Is Early Adopter of Biosimilars in U.S.

NASHVILLE, Tenn., Aug. 8, 2019 /PRNewswire/ -- OneOncology announced today that its partner practices... See more »
April 17, 2019PR Newswire

CDC Foundation, Amgen Announce Program to Increase Awareness and Knowledge of Cardiovascular Diseases Globally

ATLANTA, April 17, 2019 /PRNewswire/ -- According to the World Health Organization (WHO), cardiovascu... See more »
March 8, 2019centralcharts

Amgen To Present At The Cowen and Company 39th Annual Healthcare Conference

Amgen (NASDAQ:AMGN) will present at the Cowen and Company 39th Annual Healthcare Conference at 9:20 a... See more »
February 7, 2019PR-Inside

Molecular Partners Reports Key Financials for FY 2018 and Corporate

(PR-inside.com) Research & Development: MP0310: Molecular Partners and Amgen announced strategic coll... See more »
January 14, 2019StreetInsider

GenScript Launches Novel Technology Licensed from Amgen for Accelerating Protein and Antibody Purification

GenScript®, the world's leading gene synthesis provider, announced today at PepTalk that it has launc... See more »

Amgen Videos

October 21, 2019Amgen Youtube Channel

"Amgen Scholars Program in Singapore: Han Wei (Ryan) Soh" on YOUTUBE

See more »
October 11, 2019Amgen Youtube Channel

"Osteoporosis 101: What is osteoporosis and what you need to know" on YOUTUBE

See more »
August 30, 2019Amgen Youtube Channel

"Blood Counts: Dr. David and Ariel Siegel" on YOUTUBE

See more »
June 13, 2019Amgen Youtube Channel

"The Digital Cell Biology Revolution" on YOUTUBE

See more »
May 29, 2019Amgen Youtube Channel

"Next-Generation BioManufacturing" on YOUTUBE

See more »
October 12, 2018Amgen Youtube Channel

"Big Impact in Bio: Improving the Science of Science" on YOUTUBE

See more »
June 22, 2018Amgen Youtube Channel

"Learn what's happening at Amgen Rhode Island" on YOUTUBE

See more »

Social Statistics

Headquarters

One Amgen Center Drive

Thousand Oaks, California91320

805-447-1000

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Amgen discovers, develops, manufactures and delivers human therapeutics for patients suffering from serious illnesses. Amgen was founded in 1980. Amgen's headquarters is located in Thousand Oaks, California, USA 91320. It has raised 19.0M in 1 round. ...

CEO

Amgen's Chairman & CEO, Robert A. Bradway, currently has an approval rating of 72%. Amgen's primary competitors are AbbVie, Celgene & Coherus BioSciences.

Website

amgen.com

Frequently Asked Questions about Amgen

  1. When was Amgen founded?

    Amgen was founded in 1980

  2. Who is Amgen's CEO?

    Amgen's CEO is Robert A. Bradway

  3. How much revenue does Amgen generate?

    Amgen generates $1.2B in revenue

  4. How much funding does Amgen have?

    Amgen has historically raised $19M in funding

  5. Where is Amgen's headquarters?

    Amgen's headquarters is in Thousand Oaks California, USA

  1. How many employees does Amgen have?

    Amgen has 19,200 employees

  2. What sector does Amgen operate in?

    Amgen is in Biotechnology

  3. Who are Amgen's competitors?

    Amgen's top competitors are AbbVie, Celgene, Coherus BioSciences

  4. Who has Amgen invested in?

    Amgen's has invested in companies such as GNS Healthcare, BeiGene, Oxford Nanopore
Stay up-to-date with the latest news on Amgen